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! A new DNA aptamer against Alz-
heimer's disease biomarkers (t-441,
t-381, t-352 and t-383) was selected.
! Non-SELEX was used to isolate high-
affinity DNA sequences in one work-
ing day.
! The affinity constants were compa-
rable with those previously reported
for CE-SELEX-selected aptamers.
! A fluorescence anisotropy sensing
platform allowed the detection of the
four t-isoforms with a nM detection
limit..
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a b s t r a c t
Herein, we report for the first time the isolation of DNA aptamers directed against the whole tau protein,
an important Alzheimer's disease (AD) biomarker. Non-SELEX approach based on the capillary electro-
phoresis partitioning technique was employed to isolate a high-affinity DNA sequence pool towards the
target in only three rounds and one working day. High-throughput sequencing was next performed and
the recognition ability of five selected aptamers was preliminary evaluated by surface plasmon resonance
using the protein target immobilized on the chip. Finally, the analytical potential of the most affine
aptamer was demonstrated through the design of a homogeneous-phase fluorescence anisotropy assay.
This DNA aptamer was found to be able to recognize not only the whole t-441 but also the t-381, t-352,
t-383 isoforms. The sensing platform allowed the determination of these four targets with a detection
limit of 28 nM, 3.2 nM, 6.3 nM and 22 nM, respectively.
© 2018 Elsevier B.V. All rights reserved.
1. Introduction
The most accepted biomarkers currently used in the aid for the
AD diagnosis are the cerebrospinal fluid (CSF) amyloid beta
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peptides (Ab1-42 and Ab1-40), tau protein phosphorylated on
threonine 181 (p-t 181), and total tau protein which represents the
six isoforms (t-t) [1].
Numerous analytical methods have been described to detect
these AD markers in the biological fluid of election, i.e. CSF. The
established approaches are based on the immunoassay principles
with a variety of signaling techniques ranging from conventional
ELISA-derived systems to emerging sensing platforms based on
electrochemical, optical, and piezoelectric transduction [2]. How-
ever, immunological methods suffer from a number of drawbacks
including the analysis cost [3], the difficulty of standardization and
the assay interferences [4]. In this context, recent research efforts
have focused on the development of alternative, biomimetic
recognition elements such as peptides, molecular imprinting
polymers, and nucleic acid aptamers.
While aptamers have stimulated growing interest in both di-
agnostics and therapy, up to now only a few works have been
performed in the development of functional oligonucleotides spe-
cific to ADmarkers [5]. The reported aptamers mainly target the Ab
peptides whereas only one aptamer has been described for the
longest isoform of human t protein. Indeed, on the basis of the
well-known ability of t protein to interact with RNA molecules [6],
Kim and colleagues reported a 12-round SELEX for isolating RNA
sequences (KD in the 40e200 nM range) that are notably able to
inhibit the t oligomerization propensity [7]. However, the analyt-
ical potential of these SELEX-isolated sequences has not been yet
demonstrated. Furthermore, DNA aptamers would be more desir-
able than RNA aptamers in terms of both biostability and cost of
synthesis. The only nucleic acid sensing platform dedicated to the
t-381 detection reported up to now is based on a combined DNA-
antibody sandwich assay [8] using surface plasmon resonance
(SPR) technology. Nonetheless, contrary to what was stated by the
authors [8], the single-stranded (ss) DNA employed as the capture
element in the analytical device cannot be considered as an
aptamer (that is, selected from a large pool of random sequences)
because it was identified from only three arbitrarily chosen oligo-
nucleotides. Moreover, although one ssDNA strand exhibited a high
nanomolar dissociation constant (in the 190e350 nM range for t-
381 and t-410 respectively), the two other sequences displayed
weak-to-very weak affinities [9,10]. Finally, despite its sensitivity,
the heterogeneous-phase nature of the SPR technique requires the
careful control of the surface chemistry for the molecule attach-
ment to the chip in order to limit non-specific interactions as well
as possible detrimental effects on the recognition features of the
capture element [7].
Among SELEX methodologies, capillary electrophoresis-based
SELEX (CE-SELEX) [11e13] presents some significant advantages,
such as very low sample consumption and no need of both target
immobilization and negative selection steps [11]. This technique is
very well adapted to peptide or protein binding DNA aptamers
selectionwithout target modification, as recently demonstrated for
the aC-conotoxin PrXA target, a marine snail ultra-fast-killing
paralytic toxin [14]. A modified version of CE-SELEX, named non-
SELEX, has been subsequently reported by Krylov and co-workers.
While in conventional CE-SELEX each round is followed by Poly-
merase Chain Reaction (PCR) amplification, selection cycles in non-
SELEX are carried out without amplification steps between them,
speeding-up the selection process and alleviating the emergence of
byproducts sequences [15]. Despite the above-mentioned advan-
tages, only very few examples of aptamer isolation by non-SELEX
have been yet reported by capillary electrophoresis [16,17] or
with other methods such as PVDF membrane with only one round
of selection [18].
In this work, we aimed at identifying DNA aptamers by a fast
non-SELEX strategy in order to design a fluorescence anisotropy
(FA) aptasensing platform for the t detection. The signaling fluo-
rescence anisotropy technique displays several advantageous fea-
tures including its homogeneous-phase nature, simplicity, rapidity,
and reliability [19]. The selection of aptamers was performed by a
non-SELEX approach starting from a library of 5.1012 DNA se-
quences. High-affinity sequences for the t-441 target were identi-
fied in only 3 rounds and one working day. After high-throughput
sequencing, surface plasmon resonance [20] was used to assess the
recognition ability of five selected DNA aptamers. Finally, the
analytical potential of the best performing aptamerwas established
through the development of a FA aptasensor dedicated to four
isoforms of the t protein (t-441, t-381,t-352 and t-383).
2. Experimental section
2.1. Materials
The longest human tau protein isoform (t-441) was purchased
from Enzo Life Science (Lyon, France), supplied lyophilized and
reconstituted as recommended by the seller. The t protein isoforms
(t-381, t-352 and t-383) were obtained from Abcam (Cambridge,
UK). Human Serum Albumin (HSA), mesityloxide (MO), trizma base
(tris), glycine (gly) and all the reagents for acrylamide gel prepa-
ration were purchased from Sigma Aldrich (St Quentin Fallavier,
France). N-hydroxysuccinimide (NHS) was from Fluka (Milan,
Italy); sodium acetate and glycerol were from Carlo Erba reagents
(Milan, Italy); 1-ethyl-3-(dimethylaminopropyl) carbodiimide
(EDAC) was fromMerck (Darmstadt, Germany); 4-(2-hydroxyethyl)
piperazine-1-ethanesulfonic acid (HEPES), ethylenediaminetetra-
acetic acid (EDTA), ethanolamine hydrochloride (EA) used for SPR
experiments were all from Sigma Aldrich (Milan, Italy). Other
chemicals for buffer preparation were commercially available and
purified at analytical grade. The 77-nucleotide fluorescently labeled
single-stranded DNA (ssDNA) library and the primers used in this
study are presented in Table S1. Heavier reverse primer, and reverse
primer were from Eurofins Genomics (Ebersberg, Germany). ssDNA
library, labeled (50-FAM-) and unlabeled forward primer were from
Eurogentec (Liege, Belgium). GeneAmp 10X PCR buffer II, AmpliTaq
Gold DNA polymerase and SYBR® green PCR Kit were provided from
Applied Biosystems (Foster city, California, USA).
2.2. Procedure for R3 peptide synthesis
R3 peptide derivative was synthesized in the DCM laboratory.
Assembly of the protected R3 peptide (Ac-GGGKVQI-
VYKPVDLSKVTSKCG-CONH2) was carried out automatically on an
ABI 433 synthesizer (Applied Biosystems) by solid-phase peptide
synthesis using the standard 9-fluorenylmethoxycarbonyl/tertio-
butyl protection strategy on the rink amide MBHA resin (Nova-
Biochem®). Coupling reactions were performed in NMP using
DIPEA as base and HBTU dissolved in DMF as coupling agent.
Finally, Boc-protected aminooxyacetic acid was coupled at the N-
terminus and the peptide was cleaved from the resin using a
mixture of TFA/TIS/H2O (95:2.5:2.5). The cleaving mixture was
concentrated under vacuum and the crude was reacted with
acetone. After evaporation of the solvent, the peptide was precip-
itated in diethyl ether. It was purified by RP-HPLC on a Nucleosil C18
column (100 Å, 250 " 21 mm, 7 mm) with UVmonitoring at 214 nm
and 250 nm at a 20 mL min# 1 flow linear gradient of 5e60%
acetonitrile in water over 30 min (both water and acetonitrile
contained 0.1% TFA). After lyophilisation, the R3 peptide was
analyzed by electrospray mass spectroscopy: ESI (þ )m/z 1188.8 (m/
2), 792.9 (m/3), 595.0 (m/4).
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2.3. Non-SELEX procedure
Capillary electrophoresis selection was performed using a
Beckman Coulter P/ACE MDQ system (Fullerton, California, USA)
with exchangeable UV absorbance and laser-induced fluorescence
(LIF) detectors (lex 488 nm and lem 520 nm) equipped with an
80 cm total length (70 cm effective length) fused silica capillary
(Polymicro Technologies Inc., Phoenix, Arizona, USA) and 75 mm
inner diameter. Prior to the sample injection, the capillary was
conditioned through the following washing steps at 20 psi: 1M
NaOH for 5min, water for 5min and migration buffer (50mM Tris,
pH 8.34) for 30min. Further washing process was performed be-
tween each run at 20 psi with 1M NaOH (2min), water (2min) and
migration buffer (5min) to improve repeatability of peak migration
time. The voltage applied during separation was 20 kV for all
experiments.
Before selection, a 40 mM ssDNA library was heated to 80 %C for
5min in 4X binding buffer (final concentrations: 10mM Tris,
20mM NaCl, 1mM MgCl2; pH 8.34) and left at room temperature
for 10min. The t protein was then added to the library to a final
concentration of 7.50 mM for the first round of selection, 750 nM
and 75 nM for rounds 2 and 3, respectively. The ssDNA library was
allowed to incubate with the t protein at room temperature for at
least 20min to ensure that the binding reached equilibrium. The
equilibrated samplewas injected by applying 0.7 psi to the capillary
inlet for 40 s and detected using UV at 200 nm to monitor the
separation. Approximately 209 nL of 40 mM of DNA library (around
8.1012mol) were injected into the capillary during the first selection
round, corresponding to almost 5.1012 sequences. During a selec-
tion round, the eluate was collected into 30 mL of migration buffer
until the unbound DNA began to elute. Subsequent rounds of se-
lection used the collected DNA fraction from the previous round as
the input DNA. Immediately after migration, the collected mixture
was incubated with a new aliquot of the target (until a final volume
of 40 mL) and injected again for the new selection cycle.
Quantitative PCR experiments (q-PCR) were carried out on col-
lecting samples, issued from CE separation, to first determine
suitable target concentration to begin the selection and second to
follow sequence number. Experiments were carried out on Applied
Biosystem StepOne™ qPCR instrument (Applied Biosystem, Foster
city, California, USA) following the previously published protocol
[21]. Briefly, 2 mL of collected ssDNA were mixed with 18 mL of
SYBR® green PCR Kit (final volume 20 mL). The final concentration of
forward primer and reverse primer were kept at 10# 6M final
concentration. Thermal cycle consisted in initial denaturation at
95 %C (10min), followed by 36 amplification cycles during 15 s at
90 %C were alternated with 30 s annealing/extending step at 60 %C.
Threshold cycles (Ct) were determined for each round of selection.
2.4. PCR amplification and purification of sequences by gel
electrophoresis
Single-stranded DNA candidates were generated by PCR using a
reverse primer and a 50-FAM-labeled forward primer at the end of
the selection procedure. The reverse primer is made heavier with a
succession of six C3 links extended with a 50 DNA stretch of 20
nucleotides. During PCR, this six C3 region and the 20-nucleotide
stretch cannot be amplified by the Taq DNA polymerase. A PCR
product with two strands of unequal length is consequently syn-
thesized. Each strand is then easily purified on a denaturing poly-
acrylamide gel. All PCRs were performed using a Biometra cycler
from Labgene (Archamps, France). Master mix was made by
combining 623 mL nuclease-free water, 32 mL deoxyribonucleotide
triphosphate (dNTPs) (25mM of each) (Invitrogen, Cergy-Pontoise,
France), 10 mL each of forward and heavier reverse primers
(10# 4M), 120 mL MgCl2 (25mM), and 100 mL GeneAmp 10X PCR
buffer II. After mixing, 5 mL (5 U mL# 1) of the AmpliTaq Gold DNA
polymerase were added. To finish, 100 mL of DNA collected during
selectionwere added. This mixed solutionwas divided equally over
ten thin-walled tubes that were subjected to PCR. The thermal
cycling regime was as follows: initial denaturation for 10min at
95 %C, and then cycling for 60 s at 95 %C, 60 s at 60 %C and 90 s at
72 %C for 14 cycles. After a Nanosep® 3 K purification (Pall, Wash-
ington, New York, USA), the samples, which contained different
amounts of amplified products, were resolved on a 12% acrylamide
gel at an applied voltage of 300 V. The band corresponding to the
selected aptamers migrated with the same velocity of the library
(used as a witness) and was visualized by UV-shadow method at
254 nm. After that, it was cut and eluted for 1 h at 65 %C and 1 h at
4 %C, in 1mL of the extraction buffer (100mM Tris-HCl, 500mM
NaCl, 1mM EDTA; pH 7.4). To remove acrylamide, the extracted
product was transferred into a Nanosep® 3 K device, the retention
membrane was replaced by glass wool and the system was
centrifuged during 10min at 14,000 rpm with MIKRO 220R
centrifuge (r ¼ 87mm) (Hettic centrifuges, Tuttlingen, Germany).
Filtrate was removed, transferred in another native Nanosep® 3 K
device and centrifuged for 90min at 5000 rpm at 15 %C. The mate-
rial retained on the top of the porous membrane was washed with
100 mL of water and centrifuged again. Finally, ssDNA amount for
each round was quantified by UV absorbance at 260 nm for binding
affinity analysis of DNA pools. Three rounds of selection were per-
formed, and the progress of selection was monitored using
NECEEM to estimate the bulk affinity.
2.5. Monitoring of the non-SELEX progress
2.5.1. NECEEM-based measurement
CE separation and incubation buffer conditions were identical to
those used during the non-SELEX process. Equilibriummixture was
composed of 100 nM 50-FAM-ssDNA (original library or purified
selected pools after PCR amplification) and t protein (3 mM) incu-
bated for 30min. Samples were prepared as previously seen and
were injected by applying 0.7 psi pressure at the inlet of the
capillary for 20 s. Detection of species was insured by LIF detector.
KD values for teaptamer interaction were calculated from NECEEM
electropherograms as described in details elsewhere [22].
2.6. High-throughput sequencing
After 3 rounds of the non-SELEX procedure, an aliquot of the
library was PCR-amplified under the same conditions described
previously, except using unlabeled forward primer and free reverse
primer (Table S1). The double-stranded DNA PCR product was then
purified with MinElute PCR Purification Kit Qiagen (70 bp to 4 kb)
and eluted in very small volumes (10 mL). Next Generation
Sequencing (NGS) was used to determine aptamer sequences. Ac-
cording to the protocol, DNA concentrations were adjusted to
200 nM (Qubit® dsDNA BR Assay Kit and Qubit® 2.0 Fluorometer)
and a library was built using AB Library Builder System and Ion
Xpress Barcode. Clonal amplification was performed using the Ion
One Touch 2 system and the Ion PGM Template OT2 200 kit (all
materials were from Life Technologies SAS, Saint Aubain, France).
The sequencing step was performed using the Ion PGM™
Sequencing 200 Kit v2, the Ion 316 Chip and the PGM instrument,
Personal Genome Machine (PGM™) System (Life Technologies SAS,
Saint Aubin, France). The PGM technology is based on the detection
of releasing hydrogen ion during nucleotide incorporation in DNA
template sequences [23]. In case of all chip micro-wells, the incor-
porated dNTP and the release of a proton triggers an ion sensor and
an electrical signal indicates that a reaction has occurred. Automated
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read datasets were provided by Ion Torrent software 7.0.3 as FASTQ
format. Sequences were then processed using a software suite
named PATTERNITY-SEQ developed from the plateform aptamer in
MIRcen (http://www.cea.fr/drf/ifrancoisjacob/Pages/Departements/
MIRCen/Plateformes.aspx?Type¼ Chapitre&numero¼ 6).
Sequences corresponding to the variable region between the
primer sequences were recovered. Sequences that contain at least
one base with a quality score (Q) below 30 were removed before
further analysis, it means that the recovered sequences contain
bases with a potential probability of error below 0.001 (1 in 1000).
These sequences were then saved in a fasta format and the fre-
quency of each sequence in the library was calculated. All se-
quences were then compared to each other using the Levenshtein
distance in order to cluster them in families [24]. Enrichment of
sequence motifs were searched in the sequences of 29 and 30 nu-
cleotides using MEME (Multiple Em for Motif Elicitation, where Em
stand for the algorithm used for motif discovery) [25].
2.7. Evaluation of selected aptamers by SPR
BIAcore X™ apparatus (GE Healthcare, Uppsala, Sweden) was
used for all experiments. t protein was immobilized on a CM5
sensor chips (GE Healthcare, Uppsala, Sweden) by amino-coupling
reaction on carboxylated dextran, flowing HBS-EP buffer (10mM
HEPES, 150mM NaCl, 3mM EDTA, with 0.005% Tween 20; pH 7.4)
as suggested by the supplier. The chip dextran surfacewas activated
by the injection of 50 mM/200mM solution of NHS/EDAC (10min,
5 mLmin# 1), followed by the injection (30min, 2 mLmin# 1) of
100mg L# 1 t protein dissolved in 10mM acetate buffer at proper
pH. Optimal conditions were preliminary evaluated by a pre-
concentration test aimed to identify the best pH value for protein
immobilization. In the end, ethanolamine (1M, pH 8.5) was used to
block residual active sites (15min, 5 mLmin# 1).
To investigate relative binding abilities of the five selected
aptamers, each sequence was separately injected for 5min in the
system at 1 mM, and resulting sensorgrams were analyzed by
BIAevaluation 3.1 software. The regeneration of the biochip among
injections was carried out with short 20mM HCl pulses (1e2min).
Measurements were performed in HBS-EP (10mM HEPES, 150mM
NaCl, 3mM EDTA, with 0.005% Tween 20; pH 7.4) both as running
buffer and for aptamer dilutions. The flow rate was maintained at
5 mLmin# 1 and temperature at 25 %C.
2.8. Fluorescence anisotropy-based measurement
Once the five selected sequences evaluated, the best performing
aptamer, i.e. the 3146 one, was used as recognition element for the
development of FA homogeneous assay. FA measurements were
performed to study the binding interaction of aptamer 3146 with
the four t protein isoforms, the R3 peptide and HSA as non-cognate
protein. A Tecan Infinite F500 microplates reader (M€annedorf,
Switzerland) with 96-wells black microplates (Grenier Bio-One,
Courtaboeuf, France) was used. The working aptamer solutions
were obtained by adequate dilution of the mother solution (10# 6M
inwater) in a 2X oligonucleotide buffer (40mM Tris HCl pH 7.5 and
4mMMgCl2). After preparation, theworking solutions were heated
at 80 %C for 5min and left to stand at room temperature for 30min.
50 mg at 0.2mgml# 1 of t-381, t-383 and t-352 in 25% glycerol,
50mM Tris HCl, pH 7.5, 150mM NaCl, 0.25mM DTT and 0.1mM
PMSF were purchased from Abcam. The concentration of the stock
solution of t-381 (5 mM), t-383 (5 mM), t-352 (5.4 mM) was deter-
mined by using the calculated molecular mass of each isoform
(39.7, 40 and 36.8 kDa, respectively). These molecular masses differ
from those derived from the supplier SDS-PAGE experiments (54,
52 and 49 kDa, respectively), as SDS molecules do not bind
uniformly to all proteins [26]. These stock solutions were diluted
2.5 fold inwater. For comparative experiments, the t-441 isoform at
21.8 mM (using the calculated molecular mass) in 50mM MES pH
6.8, 100mM NaCl and 0.5mM EGTA was diluted with the 2X
concentrated target buffer (40mM Tris, pH 7.5; 120mM NaCl and
20% glycerol). HSA and R3 peptide at respectively 21.8 mM and
1.48 mM in water were prepared in the same manner. All the target
dilutions were prepared with 1X target buffer (20mM Tris, pH 7.5;
60mM NaCl and 10% glycerol).
Experiments were then performed in microplates by mixing
20 nM of 50-FAM-3146 aptamer (22.5 ml) with the same volume of
prepared targets protein dilutions. Blank wells of the microplate
received 22.5 mL of the 1X oligonucleotide buffer and 22.5 ml of the
1X target buffer in such a way that the buffer was at 20mM Tris, pH
7.5; 30mMNaCl, 5% glycerol and 1mMMgCl2. After mixing, sample
solutions were immediately analyzed. Excitation was set up at
485± 20 nm and emitted light was collected at 525± 25 nm. Ex-
periments were realized in triplicate.
Fluorescence anisotropy was directly calculated by the instru-
ment software, and the signal was expressed as the difference
(Dr ¼ r e rf) between that obtained in the presence of the target (r)
and that of the free fluorescently labeled aptamer (rf). For studying
the binding equilibrium between the t protein isoforms and
aptamer, the fraction of the t protein-bound aptamer (fb) is derived









where rb represent the anisotropy for the t protein-bound aptamer
probe, it was calculated from the model. The g parameter corre-
sponds to the quantum yield enhancement factor, which is derived
from the ratio of the total emission intensity (I) of the t protein-
bound aptamer probe (Ib) to that of the free tracer (If), i.e. Ib/If. As
frequently observed for DNA-protein associations [27], fb can be
linked to the microscopic dissociation constant of the aptamer-t
protein complex (KD) and the free concentration of t protein





where nH corresponds to the Hill coefficient that determines the
degree of binding cooperativity (<1 for noncooperative binding and
>1 for positively cooperative binding).
3. Results and discussion
3.1. Non-SELEX isolation of t-binding DNA sequences
The whole process of the non-SELEX selectionwas derived from
the previous works of Krylov and co-workers and is depicted in
Scheme 1. Briefly, the fluorescently labeled nucleic acid library (30
random nucleotides) was incubated with the protein target in the
binding buffered solution and a short plug of the equilibrium
mixture was injected onto the capillary prefilled with the run
buffer. An electric field was applied to provide the separation be-
tween the protein-bound DNA and the free DNA library under non-
equilibrium conditions. The DNA binder fractionwas then collected
from the output of the capillary and subsequently equilibrated with
the target for another CE-based partitioning step. The procedure
was repeated two more times (a total of 3 rounds) and the third
enriched DNA pool was finally PCR amplified for analysis by high-
throughput sequencing.
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Preliminary steps focused on the (i) determination of the
aptamer collection window and (ii) definition of the best initial
DNA/t ratio. The aptamer selection by non-SELEX requires optimal
electrophoretic separation between the target and the ssDNA li-
brary [29]. To this aim, we first evaluated the nucleic acid library
and t migration behavior. For the determination of the aptamer
collection window, a mixture of the protein and library was injec-
ted in the capillary and was visualized using the 200 nm wave-
length detector. Usually proteins are specifically detected at 280 nm
wavelength (Soret's band), but t absorbance in this UV region was
very low due to the little amount of aromatic amino acid residues
(low molar absorptivity coefficient of 7450M# 1 cm# 1) [30]. Protein
tmigrated faster than free ssDNA due to less negative charges, with
a great difference in migration time between the two species of
about 20min. As the mobility of the complex is conventionally
intermediate between that of free protein and free DNA, the target-
binding sequences could be easily recovered during the non-SELEX
selection through a collection window that started during the t
zone and terminated ahead the DNA peak. The choice of the target
concentration in the pre-incubated solution is another key point for
successful selection. We initially performed experiments with an
equilibrium mixture containing 750 nM of t and 40 mM of DNA li-
brary. After injection of a plug onto the capillary, a qPCR analysis of
the collected fraction was realized in order to assess the formation
of the DNA-t complex under these conditions. The Ct (threshold
cycles) value obtained for the protein-containing equilibrium
sample was almost identical to that of control (Fig. 1, red, dashed-
dot line; blue, solid line respectively). The t concentration in the
equilibrium mixture was then 10-fold increased. This approach
showed only little influence on the migration time of the species.
However, the Ct value was significantly lowered as compared with
the previous experimental set-up (6.26± 0.04 versus 17.57± 0.44).
These operative conditions revealed the formation of a more sig-
nificant amount of complex, and were then adopted as initial target
concentration for the non-SELEX partitioning.
During the three rounds of the non-SELEX selection process, the
t concentration in the equilibrium mixture was diminished from
7.5 mM (round 1) to 75 nM (round 3). The affinity evolution of the
different pools was constantly monitored by NECEEM-based mea-
surements. To achieve this, a portion of the collected DNA pools was
first PCR amplified with fluorescently-tagged primers and UV
quantitated. The resulting DNA solution (100 nM) was then mixed
with a constant protein amount (3 mM), and injected into the
capillary using the experimental selection conditions (except that
the UV detectionwas replaced by a LIF detection). As can be seen in
Fig. 2A, a peak was observed on the electropherogram at about
10min. The height of this peak increased at each round, suggesting
that it corresponded to an increase in the t-DNA complex.
Scheme 1. Summary of non-SELEX process. Randomized library is mixed with the target and injected into the capillary tube of capillary electrophoresis (Partitioning). Low affinity
ssDNA sequences are separated from high affinity ssDNA sequences because of the different electrophoretic mobility. Separation was iterated for three rounds (with no amplifi-
cation in between) prior to a single amplification step by PCR. Finally aptamer candidates were recovered by gel electrophoresis (Purification).
Fig. 1. Comparison of qPCR experiments realized after capillary electrophoretic sepa-
ration and fraction collection in 30 mL in running buffer with 40 mM of ssDNA (library
alone, blue, solid line), 40 mM of ssDNA and 750 nM t (red, dashed-dot line), and 40 mM
of ssDNA and 7.5 mM t (green, dashed line). (For interpretation of the references to
colour in this figure legend, the reader is referred to the Web version of this article.)
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Concomitantly, the free DNA peak height was diminished and it
was associated to the appearance of a significant DNA part disso-
ciated from the complex (the ‘decay bridge’). The bulk affinity of
DNA pools to the t protein can be estimated through a binding
analysis relying on the determination of peak areas for the complex,
the free DNA and the decay bridge. Due to the large portion of the
complex-dissociating DNA, a systematic method developed by
Krylov and colleagues was used to reliably determine the overlap
between the bridge and the DNA peak [31]. A constant reduction in
the apparent dissociation constant value was reported as the
number of rounds increased (Fig. 2B). The bulk affinity of the naïve
library to the target was relatively weak (apparent dissociation
constant> 2.5 mM), in accordance with previous results on the
interaction between ssDNA and the t protein [10]. A great
improvement in the binding affinity was reached for the DNA pools
from rounds 2 and 3, with a respective 30 and 60-fold decrease in
the bulk dissociation constant as compared to the initial library.
3.2. Identification of non-SELEX isolated sequences
Once the non-SELEX selection was completed, we subsequently
performed high-throughput sequencing of the DNA pool origi-
nating from the round 3. Ion torrent sequencing gave rise to a 2255
different sequences. Only 59% of the sequences have the expected
size of 30 nucleotides while most of the others have a reduced size
of a few nucleotides (Supplementary Information Fig. S1). Almost
all sequences were found at one copy and about one hundred se-
quences were found several times with a maximum of four copies
(Fig. S1B). All sequences were separated from the others with an
average Levenshtein distance of about 21 and a minimum distance
of 11, meaning that two sequences are separated by at least 11
mutations, deletions or insertions (Fig. S1C). This distance is very
large for a random region of 30 nucleotides showing that the library
is still constituted by very heterogeneous sequences, which cannot
be clustered easily into families. The sequences were then analyzed
using the MEME-suite software in order to identify conserved
motifs. However, no highly conserved motifs were identified while
the average affinity of the library was 60 times better. Such a huge
diversity of affine sequences is consistent with the intrinsic nature
of the non-SELEX selection that obviously alleviated the enrich-
ment of the DNA binders because of the lack of repeated PCR am-
plifications. Five different sequence blocks were subsequently
isolated by grouping aptamers on the basis of the predominance of
some nucleotides (group 1 with a dominance of T, and a lot of C;
group 2 with a dominance of T and a lot of G and C; group 3 with a
dominance of T and a lot of C and A; group 4with a dominance of G;
group 5 with a dominance of C). Five oligonucleotidic sequences
from each one of these groups (Table S2) were then chosen for
further binding affinity investigation.
3.3. Aptamer binding evaluation by SPR
The preliminary investigation was performed by immobilizing
the protein target on the chip surface for SPR experiments. By this
design, a fast and effective screening of the aptamers can be per-
formed to compare their binding capability towards the t protein
target under the same conditions. Before immobilizing the t pro-
tein on CM5 chip, its isoelectric point was estimated by a pre-
concentration test. This step was aimed at identifying the pH
value at which the protein is positively charged. Under this con-
dition a strong attraction between the protein and the negatively
charged dextran matrix is guaranteed, and the immobilization will
proceed with the best efficiency. As displayed in Fig. S2, the best pH
value was found at 4.0, giving an average signal of 3460± 3 Reso-
nance Unit (RU) (n ¼ 3). On the basis of this result, further immo-
bilization was performed at pH 4.00 giving a shift of RU,
DRUimm ¼ 1784 (Fig. S2). The five aptamers were then singularly
injected at the concentration of 1 mM. The resulting sensorgrams
are reported in Fig. 3, which shows that the binding capability of
aptamer 3146 was significantly higher than those of the other se-
quences. Therefore, aptamer 3146 was selected for the design of the
FA sensing platform.
3.4. Fluorescence anisotropy (FA) sensing platform
For the detection of proteins, FA aptamer-based assays rely in
most cases on a direct format. In such a case, the functional oligo-
nucleotide is terminally labeled by a fluorophore to serve as FA
probe. The signaling principle is based on the FA enhancement
according to the effective mass increase of the aptamer probe upon
Fig. 2. a) Electropherograms of the equilibrium mixture of a known amount of target
and each DNA pool collected from the three non-SELEX rounds (after PCR amplification
and purification). Traces from either free library alone or mixed with the target are also
presented for comparison. CE conditions are the identical to those of the non-SELEX
process, but with LIF detection. b) Progress of the selection procedure assessed
through the calculation of bulk KD extracted from the electropherogram data.
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complex formation with the protein [33]. In order to evaluate the
selective binding features of the aptamer 3146, both the whole t
protein target and a number of isoforms (as well as the R3 peptide)
were used as analytes. These isoforms range from 352 to 441 amino
acids and differ from each other by the presence of either three 3R
or four repeat-regions 4R (R1eR4) in the carboxy-terminal (C-ter-
minal) part of the molecule and the absence or presence of one or
two inserts (29 or 58 amino acids) in the amino-terminal (N-ter-
minal) part (Fig. S3A) [32]. A more specifically peptide (Fig. S3B)
within the repeat region corresponding to a little part of R1 and R3
peptide was also tested.
Under the binding buffer (20mM Tris, pH 7.5; 30mM NaCl, 5%
glycerol and 1mM MgCl2) conditions, the FA signal for the
fluorescein-labeled aptamer 3146 in the absence of target (rf) was
found to be relatively low for a 24 kDa species, that is comprised
between 0.074± 0.001 and 0.086± 0.001 (depending on the
experiment room temperature). This reduced value can be attrib-
uted to the local motional freedom of the fluorescein dye that
originates from the electrostatic repulsion between the polyanionic
DNA and the negatively charged fluorophore [34]. The binding of
the t proteins to the aptamer probe resulted in the increase in the
FA signal (Fig. 4). Indeed, at a protein concentration comprised
between 800 nM and 1000 nM, the measured FA signal reached
0.195± 0.000 for t-441, 0.182 ± 0.002 for t-381, 0.172± 0.001 for t-
383 and 0.179± 0.001 for t-352, leading to a great FA change of
about 0.100 in each case. Typically, as the result of the intense
segmental motion of the DNA diffusion-uncoupled dye [35], the FA
change of the fluorescein-tagged aptamer upon protein binding is
of limitedmagnitude, nomore than 0.050 [33]. Thus, the significant
response observed in the present work very likely originates from
not only the increase in the apparent molecular mass of the probe
but also from the interaction between the fluorescein label and the
t protein that would hinder the dye local movement. Moreover,
similar behavior has been previously reported by Zou et al. [36]
These authors demonstrated that the aptamer-attached fluorescein
can be strongly coupled to the target upon the complex formation
through electrostatic interactions between the anionic label and
the cationic protein, allowing a significant FA variation of about
0.120. R3 peptide did not cause any significant response over the
tested concentration range. This result did not allow us to conclude
on the aptamer-peptide interaction because of the low molecular
mass of the peptide (2.7 kDa) which probably generated only a
negligible change in the apparent mass value of the tracer. The
specificity of the sensing platform was further assessed by using
HSA as a potential non-cognate analyte. As expected, no FA varia-
tionwas observed upon addition of HSA (Fig. 4), confirming that the
signal transduction is dependent on the t binding to the aptamer
3146.
The dissociation constants for the complexes formed between
the 3146 aptamer and the four isoforms of the t protein was
determined from the Hill binding model (Table 1). We noticed that
the nH values corresponding to the Hill coefficients were different
for the target protein (t-441 ¼ 1.86± 0.19) as compared to the other
tested t-isoforms (t-381 ¼ 0.96± 0.05; t-352 ¼ 1.05± 0.065; t-
383 ¼ 1.22± 0.07). These results highlight that the recognition
mechanism of t-381, t-352, t-383 should be related to a non-
cooperative binding process whereas the binding of t-441 to the
aptamer relies on a positively cooperative phenomenon, with a nH
Fig. 3. SPR-based screening of binding ability of the five selected aptamers. A) binding curves recorded in real time by injecting 1 mM of each aptamer are reported superposed to
evidence the relative difference; B) averaged responses in terms of SPR signals showing the highest response of that aptamer 3146 respect to the other sequences tested under the
same conditions (n ¼ 3).
Fig. 4. Fluorescence anisotropy change of 50-F-Aptamer 3146 with increasing t protein
441 (red circle), 383 (white square), 381 (black square) and 352 (grey square). White
and black triangle symbols represent the data for the noncognate ligand HSA and R3
peptide, respectively. The theoretical curve (# ) is recreated using equation parameters
(see experimental section KD determination) obtained and adapted by fitting Eq (2) to
fb. Probe concentration ¼ 10 nM. Binding buffer conditions: 20mM Tris, pH 7.5; 30mM
NaCl, 5% glycerol and 1mM MgCl2. (For interpretation of the references to colour in
this figure legend, the reader is referred to the Web version of this article.)
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value of around 2. The microscopic dissociation constant was lower
for t-441 (13± 3 nM) than for t-381, t-352 and t-383 (116± 6 nM,
84± 6 nM, 49± 4 nM respectively). The calculated values, clustered
in the low-nanomolar range, are lower than most of those obtained
for protein or peptide aptamers isolated by CE-SELEX (Table 1).
Only one example of CE-SELEX-selected aptamer exhibits a lower
dissociation constant (for HIV reverse transcriptase, ranging from
180 to 500 pM, see Table 1). It is also of interest to mention that the
isolated aptamer 3146 displays about 2.25 times greater binding
features than the oligonucleotide tested by Krylova and colleagues
for the t-381 isoform (dissociation constant of ~85 nM vs 190 nM).
The analytical features of the FA aptasensor were subsequently
investigated. The estimation of the detection limit was based on the
3s/S procedure, where s is the standard deviation of the response
in the absence of target and S the slope of the titration curve linear
part. A lower detection limit was attained for t-381 and t-352 than
for t-383 and t-441 (3.2 nM and 6.3 nM compared to 22 and 28 nM
respectively). For the t-381 and t-352 isoforms, the analytical
performances of the present FA assay are similar to the previously
reported FA aptasensors dedicated to protein targets. For example,
the limits of detections (LODs) of 1 nM, 2 nM and 4.9 nM were
obtained for angiogenin [37], PDGF-BB [33] and lysozyme [36],
respectively (Table 2). Finally, the t-441 LOD was slightly higher
than those we previously reported with a monoclonal antibody-
based SPR biosensor (28 nM vs 7.8 nM) [38]. However, these ach-
ieved LODs are currently not sufficient to detect clinical levels of t
protein, which are in the pM range. Further experiments could be
performed in the future to increase the FA signal and consequently
the assay sensitivity, for instance by using mass-based amplifica-
tion approaches as previously reported for other protein targets
[39,40].
4. Conclusion
The choice of a non-SELEX strategy has accelerated the pro-
cedure of aptamer selection excluding repetitive steps of amplifi-
cation by PCR. The bulk dissociation constant of the ssDNA library
decreases from the micromolar to the nanomolar range within
three rounds, demonstrating an enrichment of binders. After high-
throughput sequencing, five selected aptamers have been chosen
and evaluated using immobilized t protein on a SPR chip. The most
responsive aptamer (named 3146) has been used as binding
element in the development of a direct FA biosensor. The calculated
dissociation constant values are better (13 nM for t-441 protein) or
comparable (116 nM, 84 nM, and 49 nM for t-381, t-352 and t-383
protein, respectively) to those classically obtained by CE-SELEX
with aptamers directed against proteins or peptides. This study
demonstrates that the aptamer 3146 could be promising as bio-
recognition element in the development of aptamer-based bio-
sensors for detecting most of the t protein isoforms.
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Table 1
Dissociation constants for previously reported aptamer-protein or peptide complexes isolated from CE SELEX methods.
Proteins/Peptides Aptamer/method Dissociation constant Ref
t-441 protein DNA/non-SELEX 13± 3 nM Our work
t-381 protein 116± 6 nM
t-352 protein 84± 6 nM
t-383 protein 49± 4 nM
aC-conotoxin PrXA DNA/CE-SELEX 120e246 nM* [14]
HE4-GST ovarian cancer biomarker DNA/CE-SELEX 280-750,000 nM** [41]
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Cdc42-GTP DNA/non-SELEX 600e2000 nM [47]
PAK1 150e600 nM
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HIVRT DNA/CE-SELEX 180e500 pM [12]
IgE DNA/CE-SELEX 27e73 nM [11]
IgE DNA/CE-SELEX 23e39 nM [49]
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**Two distinct methods.
Table 2
Limits of detection for previously reported FA direct assays dedicated to protein
targets.
Proteins Aptamer DNA Dye Detection Limit nM Ref
t-441 protein 76 mer
3146









PDGF-BB 35 mer Fluo 2 [33]
0.22*






Angiogenin 72 mer Fluo 1 [52]
Fluo for fluorescein.
FAM for 6-carboxyfluorescein.
TR for Texas Red.
TMR forTetramethylrhodamine.
*With the use of a lower aptamer concentration at the 2 nM range and with a more
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